Banner Capital Management, LLC ("Banner") today announced that it has been named to Inc's 2025 Founder-Friendly Investor List, marking the second consecutive year the firm has been recognized for its ...
Apollo (NYSE: APO) today announced that Apollo-managed funds have agreed to invest $6.5 billion in a 50% stake in Ørsted's Hornsea 3. The $6.5 billion investment ...
Apollo Global Management Inc. is partnering with venture capital firm 8VC on a new business to bring private capital to technology companies working in industries including aerospace and energy.
Zacks.com on MSN
Blue Owl Capital Inc. (OWL) Q3 Earnings Meet Estimates
Blue Owl Capital (OWL) delivered earnings and revenue surprises of 0.00% and +0.66%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Read here for an analysis of Cantillon Capital's Q3 2025 13F portfolio's key holdings, strategic moves in Broadcom, Adobe and ...
According to a filing with the Securities and Exchange Commission dated October 17, 2025, JCSD Capital, LLC liquidated its entire Block, Inc. position in the third quarter. The sale involved 40,000 ...
Innocap Investment Management Inc. (“Innocap” or “the Company”), the leading Dedicated Managed Account platform offering ...
Analysts estimate that Annaly Capital Management will report an earnings per share (EPS) of $0.72. Annaly Capital Management bulls will hope to hear the company announce they've not only beaten that ...
TipRanks on MSN
iA Financial Completes Acquisition of RF Capital, Strengthening Wealth Management Position
RF Capital Group ( ($TSE:RCG) ) has issued an announcement. iA Financial Corporation Inc. has completed its acquisition of RF Capital Group Inc., ...
Geopolitics, AI, And Israel: Bill Ackman On The Forces Shaping Global Markets (Jefferies.com) ...
Q3 2025 Earnings Call October 29, 2025 10:00 AM EDTCompany ParticipantsDavid Palamé - Executive VP, General Counsel ...
Liminatus Pharma, Inc. (NASDAQ: LIMN), La Palma, CA, a clinical-stage immuno-oncology company developing next-generation CD47-blockade therapies, announced today that it has entered into a Memorandum ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results